Ghana vs Togo: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Togo
100.0%
in 2024
Ghana rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Togo
How they compare
Ghana currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 8 times across 15 shared years of data; in 2008 it was Togo ahead.
Ghana ranks 1st and Togo ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Ghana | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 20.0% | 7.0% | Togo |
| 2010s | 75.6% | 61.3% | 14.2% | Ghana |
| 2020s | 98.6% | 92.2% | 6.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Togo?
- Ghana, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Togo?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Togo?
- 15 years are reported by both, from 2008 to 2024.
- How do Ghana and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.